Sex Hormones and Aging
Hormone-Related Mechanisms of Neuromuscular Aging and Exercise Adaptation
1 other identifier
interventional
120
1 country
1
Brief Summary
This study investigates the influence of sex hormones and exercise on age-related neuromuscular decline in females. Specifically, the research aims to evaluate how hormonal variations impact both age-associated neuromuscular decline and the subsequent adaptations to exercise and resistance training. Age-related declines in neuromuscular function are especially pronounced in females, potentially due to the sharp drop in estradiol after menopause. This project will compare postmenopausal females who have not taken hormonal therapy (HT) to age-matched females taking HT.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Aug 2026
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 20, 2026
CompletedFirst Submitted
Initial submission to the registry
September 23, 2026
CompletedFirst Posted
Study publicly available on registry
September 30, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2031
ExpectedStudy Completion
Last participant's last visit for all outcomes
August 1, 2031
September 30, 2026
September 1, 2026
5 years
September 23, 2026
September 23, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Strength - Maximal Voluntary Contraction (MVC)
Changes in MVC after 8 weeks resistance training. MVC is the greatest force generated during a brief isometric contraction.
One session before and then after 8 weeks of training
Fatigability - Reduction in Power
Reduction in limb power and maximal force in response to a dynamic fatiguing contraction.
One session before and then after 8 weeks of training
Strength - 1 Repetition Maximum
Reduction in limb power and maximal force in response to a dynamic fatiguing contraction
One session before and then after 8 weeks of training
Study Arms (2)
Postmenopausal Hormone Therapy
EXPERIMENTALPostmenopausal females who are currently taking hormone replacement therapy
Postmenopausal Female Controls
EXPERIMENTALPostmenopausal females who have no history of taking hormone replacement therapy
Interventions
Each participant will attend 2 sessions per week for 8 weeks. A training session will start with a 10-minute full body dynamic warm-up (e.g., bodyweight movements and mobility exercises). The participant will then perform bilateral lower body high-resistance strength training exercises (leg extension and leg press) for 4 sets of 8-10 repetitions.
Each participant will attend 2 sessions per week for 8 weeks. A training session will start with a 10-minute full body dynamic warm-up (e.g., bodyweight movements and mobility exercises). The participant will then perform bilateral lower body high-resistance strength training exercises (leg extension and leg press) for 4 sets of 8-10 repetitions.
Eligibility Criteria
You may not qualify if:
- Females who are pregnant or likely to be pregnant. Female subjects of childbearing age will be asked of the possibility of pregnancy and will be excluded from the study if they are pregnant or become pregnant during the study.
- Females who are not currently taking HT but have taken HT in the past 5 years.
- Severe obesity (body mass index, BMI, \> 45 kg/m2): this will be calculated from measured height and weight
- Untreated hypothyroidism
- Uncontrolled blood pressure (\>160/100 mmHg at rest)
- Epilepsy or increased risk of seizures
- Metal implants in the body, excluding the mouth
- Head injury in the past 6 months
- People who are taking any of the following medications: Medications that affect cortical excitability, Nonsteroidal anti-inflammatory drug (NSAID) use in the past 24 hours or chronic use of NSAIDs, Beta blockers or any other heart rate stabilizing medications, Any neurological, cardiovascular or musculoskeletal disease that precludes exercise testing
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Michigan
Ann Arbor, Michigan, 48109, United States
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- BASIC SCIENCE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Francie Kraker Goodridge Collegiate Professor of Kinesiology and Professor of Kinesiology, School of Kinesiology
Study Record Dates
First Submitted
September 23, 2026
First Posted
September 30, 2026
Study Start
August 20, 2026
Primary Completion (Estimated)
August 1, 2031
Study Completion (Estimated)
August 1, 2031
Last Updated
September 30, 2026
Record last verified: 2026-09
Data Sharing
- IPD Sharing
- Will not share
No data will be shared